Pricing

Atalanta Therapeutics

1 follower

‌

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.

Industries

Biotechnology, Education

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Alicia Secor

President & CEO

Alicia Secor

Collapse

Aimee L. Jackson

Chief Scientific Officer

Morgan Molloy

Chief Corporate Development Officer

Bart G. Newland

General Counsel

Michele Keough

SVP, Program & Alliance Management

Stephen Burke

SVP, Human Resources

Brittany Ferdman

Purchasing Coordinator

Anastasia Khvorova

Co-founder

Craig Mello

Co-founder

Jeff Young

Chief Financial Officer

Serena Hung

Chief Medical Officer

Antonio N.

Sr. Director Information Technology

Rachael Johnson

Executive Assistant

Teams

Scientific Research Team

11 members

Scientific and Technical Advisory

10 members

Leadership Team

7 members

Operations Team

4 members

Research and Development

5 members

Offices

Similar companies

UNC Charlotte

6 followers

Calico

6 followers

Qualigen Therapeutics

3 followers

Vera Therapeutics

2 followers

Cargo

1 follower

Capricor Therapeutics

1 follower

Edgewise Therapeutics

1 follower

Cartesian Therapeutics

1 follower

Kyverna Therapeutics

7 followers

ADARx Pharmaceuticals

3 followers

Generate Biomedicines

3 followers

Explore companies